Liberty Mutual Group Asset Management’s Abiomed Inc ABMD Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,689	Closed	-$760K	–	844
2018 Q3	$760K	Hold	1,689	–	–	0.02%	532
2018 Q2	$691K	Sell	1,689 -6,584	-80%	-$2.39M	0.02%	580
2018 Q1	$2.41M	Sell	8,273 -2,363	-22%	-$599K	0.07%	118
2017 Q4	$1.99M	Sell	10,636 -23	-0.2%	-$4.29K	0.06%	170
2017 Q3	$1.8M	Sell	10,659 -5,195	-33%	-$786K	0.1%	204
2017 Q2	$2.27M	Sell	15,854 -2,414	-13%	-$324K	0.09%	246
2017 Q1	$2.29M	Buy	18,268 +251	+1%	+$29.1K	0.09%	278
2016 Q4	$2.03M	Buy	18,017 +215	+1%	+$24.9K	0.07%	348
2016 Q3	$2.29M	Buy	17,802 +856	+5%	+$103K	0.08%	270
2016 Q2	$1.85M	Buy	+16,946	New	+$1.69M	0.07%	340

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Liberty Mutual Group Asset Management's ABMD Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 1,689 shares — an estimated $760K sold.

Liberty Mutual Group Asset Management first reported a position in ABMD in Q2 2016 and held it in 10 quarters. The position peaked at $2.41M in Q1 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Liberty Mutual Group Asset Management reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
Liberty Mutual Group Asset Management sold 1,689 Abiomed Inc shares in Q4 2018, an estimated $760K.
Liberty Mutual Group Asset Management first reported a position in Abiomed Inc in Q2 2016 and held it in 10 quarters.
Liberty Mutual Group Asset Management's Abiomed Inc position peaked at $2.41M in Q1 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.